MindMaze Therapeutics
(OTC) RLFTF
MindMaze Therapeutics Financials at a Glance
Market Cap
$60.43M
Revenue (TTM)
$12.64M
Net Income (TTM)
$63.28M
EPS (TTM)
$-1.56
P/E Ratio
-0.24
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$0.38
Volume
2,429
Open
$0.38
Price
$0.38
Volume
2,429
Open
$0.38
Previous Close
$0.38
Daily Range
$0.38 - $0.38
52-Week Range
$0.38 - $4.88
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$0.38
Volume
2,429
Open
$0.38
Previous Close
$0.38
Daily Range
$0.38 - $0.38
52-Week Range
$0.38 - $4.88
RLFTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MindMaze Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
31
CEO
Alexandre Capet
Website
www.mindmazetherapeutics.comHeadquarters
Lausanne, 1202, CH
RLFTF Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
-41%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
-4.17%
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$60.43M
Shares Outstanding
159.10M
Volume
2.43K
Short Interest
0.00%
Avg. Volume
2.55K
Financials (TTM)
Gross Profit
$5.84M
Operating Income
$18.89M
EBITDA
$16.58M
Operating Cash Flow
$2.92M
Capital Expenditure
$172.00K
Free Cash Flow
$3.09M
Cash & ST Invst.
$15.08M
Total Debt
$2.14M
MindMaze Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.22M
-59.7%
Gross Profit
$619.00K
+110.8%
Gross Margin
50.82%
N/A
Market Cap
$60.43M
N/A
Market Cap/Employee
$1.95M
N/A
Employees
31
N/A
Net Income
$4.48M
+92.1%
EBITDA
$4.01M
+20.6%
Quarterly Fundamentals
Net Cash
$10.60M
+11.0%
Accounts Receivable
$1.47M
-29.0%
Inventory
$923.00K
+105.1%
Long Term Debt
$1.53M
-34.8%
Short Term Debt
$369.00K
-58.6%
Return on Assets
N/A
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
$3.77M
+65.2%
Operating Cash Flow
$3.76M
+64.1%